Medication Name
Naltrexone
Active Ingredient
Naltrexone hydrochloride.
Drug Classification
Opioid antagonist.
Physical Description
Typically available as tablets or injectable solution.
Intended Uses
Treatment of alcohol dependence and opioid dependence.
Mechanism of Action
Blocks opioid receptors in the brain, reducing the effects of alcohol and opioids.
Dosage Forms
Available in oral tablets and injectable formulations.
Typical Dosage
For alcohol dependence: 50 mg orally per day. For opioid dependence: 380 mg intramuscularly once a month.
Administration Guidelines
Oral tablets should be taken with water. The injectable form must be administered by a healthcare provider.
Pharmacokinetics
Oral bioavailability approximately 5-40%. Peak plasma levels in about 1 hour post-oral ingestion.
Metabolism
Mainly metabolized in the liver to 6-beta-naltrexol.
Excretion
Primarily excreted in urine, with some excretion in bile.
Precautionary Screening
Patients should be opioid-free for 7-10 days before starting naltrexone therapy to avoid withdrawal symptoms.
Potential Drug Interactions
May interact with medications that affect the liver, opioid analgesics, and certain psychiatric medications.
Contraindications
Contraindicated in patients currently on opioid analgesics, with acute hepatitis, or severe liver failure.
Common Side Effects
May include nausea, headaches, dizziness, fatigue, and anxiety.
Serious Side Effects
Rare but may include liver damage, depression, and allergic reactions.
Monitoring Requirements
Liver function tests before and during treatment. Psychological evaluation to monitor for depression.
Dosing Adjustments
Adjustments may be necessary based on liver function and patient response. Consult with healthcare provider.
Missed Dose Protocol
If a dose is missed, take it as soon as remembered unless it is close to the time for the next dose.
Storage Instructions
Store at room temperature, away from moisture and heat. Keep out of reach of children.
Overdose Management
Contact emergency services immediately. Symptoms may include severe nausea and vomiting.
Pregnancy and Breastfeeding
Not recommended during pregnancy or breastfeeding unless the benefits outweigh the risks. Consult healthcare provider.
Patient Counseling
Inform patients about the potential for liver damage and the importance of regular liver function tests.
Duration of Therapy
Varies depending on individual patient needs and response. Long-term therapy may be necessary.
Dispensing Instructions
Ensure the correct form of medication is provided (tablet or injectable). Verify dosage instructions with patient.
Patient Assistance Programs
Some pharmaceutical companies offer financial assistance programs to help cover the cost of naltrexone.
Alternative Treatments
Alternative medications for alcohol and opioid dependence include acamprosate, methadone, and buprenorphine.
Physician Collaboration
Close collaboration with prescribing physician is essential to ensure safe and effective use.
Legal Considerations
Classified as a non-controlled substance but may be subject to prescription regulations.
Research Studies
Clinical studies indicate efficacy in reducing alcohol and opioid consumption when used as part of a comprehensive treatment program.
Patient Education
Educate patients about the importance of adherence to treatment and the potential consequences of missing doses.
Insurance Coverage
Most insurance plans cover naltrexone, but prior authorization may be required.
Comparative Efficacy
Studies show naltrexone is effective but may be less effective than some opioid agonist therapies for opioid dependence.
Withdrawal Symptoms
Not commonly associated with withdrawal symptoms but may precipitate withdrawal in those currently using opioids.